TFS is a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies. Headquartered in Lund, TFS serves global clinical trial markets with local expertise and worldwide project delivery. János Filakovský, MD, Ph.d. MBA, CEO of TFS, discusses the company’s unique capabilities and analyzes the Swedish life sciences industry's potential to become the leader in e-health and new treatments.
The biopharmaceutical industry is continuously changing and we realize how important it is to support our customers throughout their clinical development journey.
